Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;62(9):1176-1185.
doi: 10.1111/ijd.16754. Epub 2023 Jun 20.

Acne characteristics in Latin American patients and the potential role of trifarotene

Marco A D da Rocha  1 , Leonel Fierro-Arias  2 , Emilia N Cohen Sabban  3 , Ricardo S Castillo  4 , Rajeev Chavda  5 , Luiz M Almeida  6
Affiliations

Acne characteristics in Latin American patients and the potential role of trifarotene

Marco A D da Rocha et al. Int J Dermatol. 2023 Sep.

Abstract

Background: Individualization of treatment based on acne type and severity, location, disease burden, and patient preference is required to maximize efficacy, safety, and adherence to therapy. Latin American populations have unique attributes that must be considered as part of this process to improve clinical success and achieve patient goals. Acne is more common among patients with darker skin phototypes, in whom it is often associated with postinflammatory hyperpigmentation and scarring-the most important acne sequelae-potentially due to more frequent and more severe underlying inflammatory processes in this population.

Discussion: These data argue for an early and proactive approach to managing acne in these patients with agents that target the inflammatory processes that underlie acne and its sequelae. As a class, retinoids offer a spectrum of activity that may be useful in addressing the unique needs of Latin American populations.

Conclusion: Trifarotene, a novel, selective retinoid, has been evaluated in relevant patient populations.

PubMed Disclaimer

References

    1. Dréno B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21:18-24.
    1. Zaenglein AL. Acne vulgaris. N Engl J Med. 2018;379:1343-52.
    1. Tan J, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, et al. The personalised acne care pathway-recommendations to guide longitudinal management from the personalising acne: consensus of experts. JAAD Int. 2021;5:101-11.
    1. Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58:56-9.
    1. Ramrakha S, Fergusson DM, Horwood LJ, Dalgard F, Ambler A, Kokaua J, et al. Cumulative mental health consequences of acne: 23-year follow-up in a general population birth cohort study. Br J Dermatol. 2016;175:1079-81.

Grants and funding